Physician profile
David A Feldmar
NPI 1083817704
$8,346.22
in general payments reported to CMS, 2019-2025
32 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,345 · 2020: $735 · 2021: $883 · 2022: $941 · 2023: $1,050 · 2024: $2,339 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,773 · Travel and Lodging: $627 · Education: $42.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,773.00 |
| Travel and Lodging | $627.24 |
| Education | $42.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,901.47 | 2023-2025 | |
| Allergan, INC. | $1,223.37 | 2019-2022 | |
| Solventum Corporation | $1,156.39 | 2024 | Promogran Prisma, V.A.C. Dermatac, Snap |
| Merz North America, INC. | $603.47 | 2019-2025 | |
| Galderma Laboratories, L.P. | $474.32 | 2019-2024 | Dysport |
| Celularity INC. | $406.85 | 2019-2020 | |
| Sientra, INC. | $289.49 | 2022 | |
| Integra Lifesciences Corporation | $256.74 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $232.31 | 2020-2021 | |
| Revance Therapeutics, INC. | $215.77 | 2024-2025 | Daxxify, Daxi |
| Novo Nordisk INC | $189.55 | 2021-2024 | Wegovy |
| Smith+Nephew, INC. | $151.43 | 2020-2023 | Collagenase Santyl, Grafix |
| Misonix INC | $149.16 | 2019-2021 | |
| Apyx Medical Corporation | $145.86 | 2019 | |
| Mimedx Group, INC. | $108.96 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $98.42 | 2022 | |
| Bioventus LLC | $98.23 | 2022-2023 | |
| Lilly USA, LLC | $80.93 | 2023-2025 | Zepbound, Mounjaro |
| Kci USA, INC. | $68.58 | 2023 | Activ.A.C. |
| Lifenet Health | $66.29 | 2023-2024 | Theragenesis Wound Matrix |
| Tela Bio, INC. | $64.74 | 2024 | Ovitex 2s |
| Tepha INC | $60.42 | 2019-2020 | |
| Gilead Sciences, INC. | $59.34 | 2025 | Trodelvy |
| Acell, INC. | $48.82 | 2019 | |
| Organogenesis INC. | $33.48 | 2024 | Apligraf |
| Kerecis Limited | $30.88 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Osiris Therapeutics INC. | $28.87 | 2019 | |
| Davol INC. | $24.51 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $23.94 | 2025 | |
| Aroa Biosurgery Incorporated | $23.81 | 2024 | |
| Mckesson Medical-Surgical, INC. | $16.47 | 2019 | |
| Convatec INC. | $13.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Feldmar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.